[Double-blind comparative clinical study of cefpiramide (SM-1652) and cefmetazole in complicated urinary tract infections]

Autor: Joji ISHIGAMI, Sadao KAMIDONO, Sohichi ARAKAWA, Nobumasa KATAOKA, Koji NAKANO, Masuyoshi HARADA, Kyubei HIROOKA, Nobori SHIMATANI, Atsushi ITANI, Masami MATSUSHITA, Koji HIKOSAKA, Osamu MATSUMOTO, Kakuyoshi OHYA, Noboru ITO, Kenji HARADA, Toshikazu KIYOTA, Hiroshi SAITO, Yoshihiko KITANO, Yasumasa TAKAHASHI, Shinji HARA, Hiroshi OHMAE, Toru OHBE, Hirohiko YASUNO, Nobuo KATAOKA, Hiroshi OKUDAIRA, Gaku KAWABATA, Hideo OHSHIMA, Shusoo DEN, Osamu TOMIOKA, Shigenori TADERA, Hiroshi UEHARAGUCHI, Yoshinori ODA, Hiroshi YAMAZAKI, Kenichi TAKADA, Yasunaga OKADA, Suguru HINENO, Yasuji KURODA, Shunro MOMOSE, Mineo TAKEI, Joichi KUMAZAWA, Seiichi NAKAMUTA, Kimitaka SAKAMOTO, Kazuhiro OSHIMA, Nobuyuki ISHIZAWA, Yukio OSADA, Sanshin HARA, Kanichi EMOTO, Kozo HIRATA, Ichikiro MORITA, Kunihiro MINODA, Haruka HIRANO, Hiroyuki NAGAYOSHI, Shinichi SATO, Tetsuo OMOTO, Hiroaki YAGI, Hiroshi HIRATA, Sadamu ANDO, Eiji IWATSUBO, Shinichiro KOMINE, Nobuya OGAWA

Publikováno v: Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases. 57(8)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44e5e927408536b5327b4a3f9b0d6a89
https://pubmed.ncbi.nlm.nih.gov/6420483